Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Ioana Maria Lambrescu"'
Autor:
Emilia Manole, Cristina Niculite, Ioana Maria Lambrescu, Gisela Gaina, Octavian Ioghen, Laura Cristina Ceafalan, Mihail Eugen Hinescu
Publikováno v:
Biomolecules, Vol 11, Iss 5, p 697 (2021)
Macrophages (MCs) are present in all tissues, not only supporting homeostasis, but also playing an important role in organogenesis, post-injury regeneration, and diseases. They are a heterogeneous cell population due to their origin, tissue specifici
Externí odkaz:
https://doaj.org/article/f67cf34c49354a39b1e6fccce4ac5e27
Autor:
Ancuța-Augustina Gheorghișan-Gălățeanu, Andreea Ilieșiu, Ioana Maria Lambrescu, Dana Antonia Țăpoi
Publikováno v:
International Journal of Molecular Sciences. 24:1418
Neuroendocrine neoplasms (NENs) originate from the neuroendocrine cell system, which may either take the shape of organoid cell aggregations or be composed of dispersed cells across various organs. Therefore, these tumors are heterogenous regarding t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f4e6a0db5460d725a727c73a1ced5e45
https://doi.org/10.3390/ijms24021418
https://doi.org/10.3390/ijms24021418
Publikováno v:
Neuro endocrinology letters. 43(1)
Neuroendocrine neoplasms (NENs) are an extremely heterogeneous medical entity, representing a diagnostic and therapeutic challenge. Chronic inflammation, as is the case with other malignancies, plays a crucial role in NEN carcinogenesis.The complete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::601e0562046e3f4741168728158a16a9
https://pubmed.ncbi.nlm.nih.gov/35786807
https://pubmed.ncbi.nlm.nih.gov/35786807
Autor:
Gisela Gaina, Laura Cristina Ceafalan, Mihail Eugen Hinescu, Octavian Ioghen, Ioana Maria Lambrescu, Cristina Mariana Niculite, Emilia Manole
Publikováno v:
Biomolecules
Biomolecules, Vol 11, Iss 697, p 697 (2021)
Biomolecules, Vol 11, Iss 697, p 697 (2021)
Macrophages (MCs) are present in all tissues, not only supporting homeostasis, but also playing an important role in organogenesis, post-injury regeneration, and diseases. They are a heterogeneous cell population due to their origin, tissue specifici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b744a316a4e239a217d62128038add0
http://europepmc.org/articles/PMC8148606
http://europepmc.org/articles/PMC8148606
Autor:
Iulia Soare, Cima Luminita Nicoleta, Alexandra Vadana, Ioana Maria Lambrescu, Simona Fica, Sorina Martin
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd2baa177b302338fea50cc04c88383
https://doi.org/10.1530/endoabs.70.aep944
https://doi.org/10.1530/endoabs.70.aep944
Autor:
Anca Colita, Luminita Cima, Sorina Martin, Lavinia Stejereanu, Cristina Zaharia, Ioana Maria Lambrescu, Simona Fica
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 31:869-878
Background: Thyroid dysfunction (TD) was usually described in hematopoietic stem cell transplantation (HSCT) recipients who were given total body irradiation (TBI) in the conditioning regimen. Because previous studies have reported discrepant results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4d7ac92d53ee689061b43535f979fc
https://doi.org/10.1515/jpem-2018-0020
https://doi.org/10.1515/jpem-2018-0020
Autor:
Ioana Maria Lambrescu, Reuven Or, Luminita Cima, Simona Fica, Anca Colita, Lavinia Stejereanu
Publikováno v:
Clinical Case Reports
Key Clinical Message A few cases of thyroid eye disease following alemtuzumab therapy have been described in patients with multiple sclerosis. Our patient is the first case of Graves’ orbitopathy after alemtuzumab conditioning for hematopoietic ste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c724c5bd9987fc26bb799ce78a5e21f8
http://europepmc.org/articles/PMC5930230
http://europepmc.org/articles/PMC5930230
Autor:
Cristina Mariana Niculite, Ioana Maria Lambrescu, Valeriu B. Cismasiu, Gisela Gaina, A. Popa, V.S. Ionescu
Publikováno v:
Annals of Oncology. 32:S1358
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0497c3e284db302969496dc8e574d241
https://doi.org/10.1016/j.annonc.2021.08.2038
https://doi.org/10.1016/j.annonc.2021.08.2038
Publikováno v:
Expert Opinion on Orphan Drugs. 5:525-536
Introduction: Everolimus, an inhibitor of mammalian target of rapamycin (mTOR), is approved as an anti-tumor therapy, as single agent or in combination, for advanced neuroendocrine tumors (NETs), breast and renal carcinomas.Areas covered: In this rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::863bcd03a17c0775e6ce92c9056340f2
https://doi.org/10.1080/21678707.2017.1334550
https://doi.org/10.1080/21678707.2017.1334550
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81b819210e029af37dd7da3090d0baed
https://doi.org/10.1530/endoabs.56.ep108
https://doi.org/10.1530/endoabs.56.ep108